Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06267365 · ClinicalTrials.gov registry record
Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis
A clinical trial of Chronic Pancreatitis, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06267365 is a study of Chronic Pancreatitis that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 687-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06267365, a study of Chronic Pancreatitis, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational prospective study to develop predictive biomarkers for pain response in participants with chronic pancreatitis scheduled for endoscopic therapy. Participants will undergo baseline assessments including electroencephalography (EEG), quantitative sensory testing (QST), and psychosocial questionnaires. Response to endoscopic therapy will be assessed at approximately 3, 6, 12 and 18 months post-procedure using questionnaires.
Conditions Studied
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-27 |
| Est. Completion | 2028-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06267365
The ClinicalTrials.gov registry entry for NCT06267365 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 687-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (85% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 0 interventions.
NCT06267365 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06267365 about?
NCT06267365 is a clinical study titled "Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis". This is an observational prospective study to develop predictive biomarkers for pain response in participants with chronic pancreatitis scheduled for endoscopic therapy. Participants will undergo baseline assessments including electroencephalography (EEG), quantitative sensory testing (QST), and psy...
What is the current status of trial NCT06267365?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-11-27. Estimated completion is 2028-06-01.
What conditions does trial NCT06267365 study?
This clinical trial studies the following conditions: Chronic Pancreatitis.
Who is sponsoring clinical trial NCT06267365?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06267365 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
-
Analysis of Graft Function Following Autologous Islet Transplantation
RECRUITING
-
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
RECRUITING · Early Phase 1
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RECRUITING
-
Pancreas Registry and High Risk Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.